MedPath

Does additional steroid help improve success in glaucoma surgery

Phase 4
Conditions
Health Condition 1: H401- Open-angle glaucomaHealth Condition 2: H402- Primary angle-closure glaucoma
Registration Number
CTRI/2024/04/066490
Lead Sponsor
Medical research foundation, Sankara Nethralaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Primary glaucoma on topical IOP lowering medication for at least 6 months

Glaucoma not controlled on medical therapy

Patient intolerant to topical IOP lowering medication for IOP control

Glaucoma controlled on medical therapy but patient with more than two IOP lowering medication undergoing cataract surgery

Age atleast eighteen years or older

Snellen best corrected visual acuity of 6/60 or better

Exclusion Criteria

Any patient with uncontrolled IOP and glaucomatous damage requiring surgical intervention at the earliest and hence unable to take the preoperative topical steroid course

Active severe inflammation requiring topical steroids within the last 3 months

History of Yttrium Aluminum Garnet peripheral iridotomy (YAG PI) within the last 3 months

Those with history of laser trabeculoplasty

Prior surgery other than uncomplicated clear corneal phacoemulsification

Other ocular pathology including retinal pathology, uveitis

Secondary glaucoma including but not limited to steroid induced glaucoma, ICE syndrome, pseudoexfoliation glaucoma, pigment dispersion syndrome, neovascular glaucoma

History of ocular trauma in the eye planned for trabeculectomy

Myopia more than 6D/ pathological myopia

One eyed patients

Pregnant or nursing women

Concurrent or steroid use within last 3months for other diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath